Feasibility of dosimetry-based high-dose 131I-meta-iodobenzylguanidine with topotecan as a radiosensitizer in children with metastatic neuroblastoma.

Gaze, Mark N

Feasibility of dosimetry-based high-dose 131I-meta-iodobenzylguanidine with topotecan as a radiosensitizer in children with metastatic neuroblastoma. [electronic resource] - Cancer biotherapy & radiopharmaceuticals Apr 2005 - 195-9 p. digital

Publication Type: Journal Article

1084-9785

10.1089/cbr.2005.20.195 doi


3-Iodobenzylguanidine--pharmacology
Child
Child, Preschool
Dose-Response Relationship, Radiation
Female
Humans
Iodine Radioisotopes--pharmacology
Male
Neoplasm Metastasis
Neuroblastoma--therapy
Radiation Dosage
Radiation-Sensitizing Agents--pharmacology
Radiometry--methods
Radiopharmaceuticals--pharmacology
Radiotherapy Dosage
Topotecan--pharmacology
Whole-Body Counting